Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug;58(4):336-344.
doi: 10.1177/00185787221101480. Epub 2022 Dec 21.

Maribavir

Affiliations
Review

Maribavir

Terri L Levien et al. Hosp Pharm. 2023 Aug.

Abstract

Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433.

Keywords: anti-infectives; drug information; formulary management/P & T.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Livtencity (maribavir) [prescribing information]. Takeda Pharmaceuticals America Inc; 2021.
    1. Razonable RR, Humar A. Cytomegalovirus in solid organ transplant recipients-Guidelines of the American Society of Transplantation Infectious Diseases Community of practice. Clin Transplant. 2019;33(9):e13512. doi:10.1111/ctr.13512 - DOI - PubMed
    1. Cidofovir [Prescribing Information]. Mylan Institutional LLC; 2021.
    1. Orange Book. Approved Drug Products with Therapeutic Equivalence Evaluations. Food and Drug Administration. Updated January 2022. Accessed January 19, 2022. https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
    1. Foscavir (foscarnet sodium) [prescribing information]. Hospira Inc; 2020.

LinkOut - more resources